CEO

Michael Benjamin Crowe is a computational chemist, mycology entrepreneur, author, and systems architect whose work bridges traditional natural product discovery with cutting-edge artificial intelligence for pharmaceutical applications. As CEO and Founder of Crowe Logic, Inc. (founded October 2025), he leads development of machine learning infrastructure, high-quality training datasets, and cheminformatics platforms for drug discovery while maintaining deep expertise in fungal cultivation, bioactive compound extraction, and natural product chemistry. PHARMACEUTICAL AI & COMPUTATIONAL CHEMISTRY Crowe's current research centers on creating large-scale, production-ready training datasets for pharmaceutical machine learning. His work emphasizes quality-tiered architectures (Gold/Silver/Bronze/Training) for molecular property prediction, compound-target interaction modeling, and drug discovery applications. He has developed multi-million scale datasets with novel IP protection systems including cryptographic watermarking and synthetic compound registries. Key innovations include CriOS Nova (comprehensive cheminformatics platform), CroweChain (federated learning architecture reducing costs by >95%), and cost-optimization strategies enabling $50 dataset generation vs. $100K+ traditional approaches. Research focus: Multi-million scale molecular dataset generation, deep learning for pharmaceutical property prediction, cheminformatics platform development, natural product chemistry integration with computational methods, IP protection systems, and federated learning for collaborative pharmaceutical development. MYCOLOGY & NATURAL PRODUCT DISCOVERY Crowe's foundation in mycology provides unique insights into bioactive compound discovery. Expertise spans fungal cultivation systems, substrate engineering, dual-phase bioactive extraction protocols (for Lion's Mane, Reishi, Ganoderma), and environmental intelligence. This interdisciplinary approach enables AI-assisted strain-site matching, bioactive compound discovery from fungal metabolomes, and integration of traditional knowledge with computational predictions. Founded Southwest Mushrooms and developed the Crowe Logic™ AI Behavior Core framework for standardizing scientific protocols across cultivation, extraction, and field deployments. Authored: "A Journey Into Mycology" and "The Power of Mindset in Mycology Entrepreneurship." Extensive technical documentation (7,959+ lines) covering pharmaceutical dataset methodologies, quality assurance systems, and deployment strategies. CURRENT INITIATIVES: Large-scale pharmaceutical dataset releases, CriOS Nova platform deployment, CroweChain implementation, community edition launches, and integration of natural product databases with computational chemistry tools. Website: https://crowelogic.com